“Stability of Sulfadiazine Sugar-Free Oral Suspensions for the Treatment of Congenital Toxoplasmosis”. Brazilian Journal of Pharmaceutical Sciences, vol. 59, Nov. 2023, https://doi.org/10.1590/.